Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Johan Ahlgren, Gunnar Westman, Olle Stål & Lars-Gunnar Arnesson. (1994) Prediction of Axillary Lymph Node Metastases in a Screened Breast Cancer Population. Acta Oncologica 33:6, pages 603-608.
Read now
Read now
Adri C. Voogd, Mike W. P. M. van Beek, Mariad A. Crommelin, Huub M. Kluck & Jan Willem W. Coebergh. (1994) Management of Early Breast Cancer in Southeast Netherlands Since 1984 A Population-Based Study. Acta Oncologica 33:7, pages 753-757.
Read now
Read now
N. Wilking, L. E. Rutqvist, J. Carstensen, A. Mattsson & L. Skwg. (1992) Prognostic Significance of Axillary Nodal Status in Primary Breast Cancer in Relation to the Number of Resected Nodes. Acta Oncologica 31:1, pages 29-35.
Read now
Read now
Articles from other publishers (65)
Peiwen Wu, Dongjie He, Shuchai Zhu, Hao Chang, Qiming Wang, Qiuju Shao & Gaiyan Li. (2022) The role of postoperative radiation therapy in stage I–III male breast cancer: A population-based study from the surveillance, epidemiology, and End Results database. The Breast 65, pages 41-48.
Crossref
Crossref
Sungchan Gwark, Woo Chul Noh, Sei Hyun Ahn, Eun Sook Lee, Yongsik Jung, Lee Su Kim, Wonshik Han, Seok Jin Nam, Gyungyub Gong, Seon-Ok Kim & Hee Jeong Kim. (2021) Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Gabriel A. De la Cruz‐Ku, Diego Chambergo‐Michilot, Bryan Valcarcel, Pamela Rebaza, Mecker Möller, Jhajaira M. Araujo, Daniel Enriquez, Zaida Morante, Cesar Razuri, Renato Luque, Antonella Saavedra, Eduardo Eyzaguirre, Maria Lujan, Naysha Noel, Joseph Pinto, Jose Cotrina & Henry Gomez. (2020) Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy. The Breast Journal 26:9, pages 1659-1666.
Crossref
Crossref
Jeeyeon Lee, Jin Hyang Jung, Wan Wook Kim, Ryu Kyung Lee, Hye Jung Kim, Won Hwa Kim, Ji-Young Park, Ji-Yun Jeong, Yee Soo Chae, Soo Jung Lee, Shin-Hyung Park, Mi Young Kim, Jung Dug Yang, Jeong Woo Lee, Joon Seok Lee & Ho Yong Park. (2019) 5-year oncological outcomes of targeted axillary sampling in pT1-2N1 breast cancer. Asian Journal of Surgery 42:6, pages 681-687.
Crossref
Crossref
Reshu Agarwal, Arun Philip, Keechilat Pavithran, Anupama Rajanbabu, Gaurav Goel & DK Vijaykumar. (2019) Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy. Indian Journal of Cancer 56:3, pages 228.
Crossref
Crossref
Laura S. Dominici, Helmneh M. Sineshaw, Ahmedin Jemal, Chun Chieh Lin, Tari A. King & Rachel A. Freedman. (2017) Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt. Breast Cancer Research and Treatment 167:2, pages 555-566.
Crossref
Crossref
D. Robert Siemens, William J. Mackillop, Yingwei Peng, Xuejiao Wei, David Berman & Christopher M. Booth. (2015) Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study. Urologic Oncology: Seminars and Original Investigations 33:10, pages 425.e15-425.e23.
Crossref
Crossref
B. Ataseven, S. Kümmel, W. Weikel, F. Heitz, J. Holtschmidt, F. Lorenz-Salehi, A. Kümmel, A. Traut, J. Blohmer, P. Harter & A. du Bois. (2014) Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients. Archives of Gynecology and Obstetrics 291:5, pages 1153-1166.
Crossref
Crossref
Michael Rink, Shahrokh F. Shariat, Evanguelos Xylinas, John P. Fitzgerald, Jens Hansen, David A. Green, Ashish M. Kamat, Giacomo Novara, Siamak Daneshmand, Yves Fradet, Scott T. Tagawa, Patrick J. Bastian, Wassim Kassouf, Quoc-Dien Trinh, Pierre I. Karakiewicz, Hans-Martin Fritsche, Derya Tilki, Felix K. Chun, Bjoern G. Volkmer, Marko Babjuk, Axel S. Merseburger, Douglas S. Scherr, Yair Lotan & Robert S. Svatek. (2012) Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?. World Journal of Urology 30:6, pages 807-814.
Crossref
Crossref
Kathryn T. Chen. (2012) Axillary Dissection. Current Problems in Cancer 36:5, pages 245-262.
Crossref
Crossref
Marie Catherine Lee, Robert Plews, Bhupendra Rawal, John V. Kiluk, Loretta Loftus & Christine Laronga. (2011) Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review. Annals of Surgical Oncology 19:6, pages 1818-1824.
Crossref
Crossref
Conrad B. Falkson. (2011) How Do I Deal With the Axilla in Patients With a Positive Sentinel Lymph Node?. Current Treatment Options in Oncology 12:4, pages 389-402.
Crossref
Crossref
Nakul Saxena, Mikael Hartman, Rezal Aziz, Elisabetta Rapiti, Nirmala Bhoo Pathy, Siew Eng Lim, Philip Iau, Nur Aisha Taib, Robin Schaffar, Isabelle Neyroud-Caspar, Cheng Har Yip, Soo Chin Lee & Helena M. Verkooijen. (2011) Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre study. European Journal of Cancer 47:8, pages 1186-1192.
Crossref
Crossref
Judy C. Boughey, John H. Donohue, James W. Jakub, Christine M. Lohse & Amy C. Degnim. (2010) Number of lymph nodes identified at axillary dissection. Cancer 116:14, pages 3322-3329.
Crossref
Crossref
Pankaj P. Dangle, Robert R. Bahnson & Kamal S. Pohar. (2009) How close are we to establishing standards of lymphadenectomy for invasive bladder cancer?. Therapeutic Advances in Urology 1:3, pages 167-174.
Crossref
Crossref
T. Cil, J. Hauspy, H. Kahn, S. Gardner, W. Melnick, C. Flynn & C. M. B. Holloway. (2008) Factors Affecting Axillary Lymph Node Retrieval and Assessment in Breast Cancer Patients. Annals of Surgical Oncology 15:12, pages 3361-3368.
Crossref
Crossref
Claude Nos, Gabriel Kaufmann, Krishna B. Clough, Marie-Anne Collignon, Eric Zerbib, Pino Cusumano & Fabrice Lecuru. (2008) Combined Axillary Reverse Mapping (ARM) Technique for Breast Cancer Patients Requiring Axillary Dissection. Annals of Surgical Oncology 15:9, pages 2550-2555.
Crossref
Crossref
. 2008. Treatment Methods for Early and Advanced Prostate Cancer. Treatment Methods for Early and Advanced Prostate Cancer
119
124
.
G.P. Kuijt, L.V. van de Poll-Franse, A.C. Voogd, G.A.P. Nieuwenhuijzen & R.M.H. Roumen. (2007) Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. European Journal of Surgical Oncology (EJSO) 33:7, pages 832-837.
Crossref
Crossref
Anees B. Chagpar, Charles R. Scoggins, Robert C. G. Martin, Sunati Sahoo, David J. Carlson, Alison L. Laidley, Souzan E. El-Eid, Terre Q. McGlothin & Kelly M. McMasters. (2007) Factors Determining Adequacy of Axillary Node Dissection in Breast Cancer Patients. The Breast Journal 13:3, pages 233-237.
Crossref
Crossref
C K Axelsson, H T Mouridsen, M Düring & S Møller. (2007) Axillary staging during surgery for breast cancer. British Journal of Surgery 94:3, pages 304-309.
Crossref
Crossref
Bekir Kuru & Mustafa Bozgul. (2006) The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. International Journal of Radiation Oncology*Biology*Physics 66:5, pages 1328-1334.
Crossref
Crossref
Sue A. Joslyn & Badrinath R. Konety. (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68:1, pages 121-125.
Crossref
Crossref
OZGUR UGURLU, OZTUG ADSAN, MESUT TUL, MURAT KOSAN, GURDAL INAL & MESUT CETINKAYA. (2006) Value of frozen sections of lymph nodes in pelvic lymphadenectomy in patients with invasive bladder tumor. International Journal of Urology 13:6, pages 699-702.
Crossref
Crossref
JOHN P. STEIN, MARCUS L. QUEK & DONALD G. SKINNER. (2006) Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors. BJU International 97:2, pages 232-237.
Crossref
Crossref
M Hammad Ather, Sadaf Fatima & Orhun Sinanoglu. (2005) Extent of lymphadenectomy in radical cystectomy for bladder cancer. World Journal of Surgical Oncology 3:1.
Crossref
Crossref
William C Huang & Bernard H Bochner. (2005) Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer. Current Opinion in Urology 15:5, pages 315-319.
Crossref
Crossref
Fiona C Burkhard, Martin Schumacher & Urs E Studer. (2005) The role of lymphadenectomy in prostate cancer. Nature Clinical Practice Urology 2:7, pages 336-342.
Crossref
Crossref
M. Schumacher, F. C. Burkhard & U. E. Studer. (2005) Stellenwert der pelvinen Lymphadenektomie beim klinisch lokalisierten ProstatakarzinomThe role of pelvine lymphadenectomy in prostate cancer. Der Urologe, Ausgabe A 44:6, pages 645-651.
Crossref
Crossref
Sue A. Joslyn, S. Joseph Sirintrapun & Badrinath R. Konety. (2005) Impact of lymphadenectomy and nodal burden in renal cell carcinoma: Retrospective analysis of the National Surveillance, Epidemiology, and End Results database. Urology 65:4, pages 675-680.
Crossref
Crossref
David G. Sheldon. (2005) Beyond lymph node staging: molecular predictors of outcome in breast cancer. Surgical Oncology Clinics of North America 14:1, pages 69-84.
Crossref
Crossref
Jacqueline Sara Jeruss, David J. Winchester, Stephen F. Sener, Erika M. Brinkmann, Malcolm M. Bilimoria, Ermilo BarreraJr.Jr., Eihab Alwawi, Angel Nickolov, G. M. Schermerhorn & David J. Winchester. (2004) Axillary Recurrence After Sentinel Node Biopsy. Annals of Surgical Oncology 12:1, pages 34-40.
Crossref
Crossref
Debra L. Breneman, Paul E. Steele, Hernani D. Cualing, John C. Breneman, Michael S. Nussbaum & Steven H. Swerdlow. (2004) Reply. Journal of the American Academy of Dermatology 51:3, pages 483-484.
Crossref
Crossref
David Krag, Seth Harlow & Thomas Julian. (2004) Breast cancer and the NSABP-B32 sentinel node trial. Breast Cancer 11:3, pages 221-224.
Crossref
Crossref
Fiona C Burkhard & Urs E Studer. (2004) The role of lymphadenectomy in prostate cancer. Urologic Oncology: Seminars and Original Investigations 22:3, pages 198-202.
Crossref
Crossref
Frans D. Rahusen, Sybren Meijer, Annette H. M. Taets van Amerongen, Rik Pijpers & Paul J. van Diest. (2003) Sentinel Node Biopsy for Nonpalpable Breast Tumors Requires a Preoperative Diagnosis of Invasive Breast Cancer. The Breast Journal 9:5, pages 380-384.
Crossref
Crossref
A.R. Jensena, M. Ewertz, S. Cold, H.H. Storm & J. Overgaard. (2003) Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. European Journal of Cancer 39:12, pages 1783-1793.
Crossref
Crossref
F.J. Hoar & P.S. Stonelake. (2003) A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer. European Journal of Surgical Oncology 29:6, pages 526-531.
Crossref
Crossref
George N Thalmann, Achim Fleischmann, Robert D Mills, Fiona C Burkhard, Regula Markwalder & Urs E Studer. (2003) Lymphadenectomy in Bladder Cancer. EAU Update Series 1:2, pages 100-107.
Crossref
Crossref
BADRINATH R. KONETY, SUE A. JOSLYN & MICHAEL A. O’DONNELL. (2003) Extent of Pelvic Lymphadenectomy and Its Impact On Outcome in Patients Diagnosed With Bladder Cancer: Analysis of Data From the Surveillance, Epidemiology and End Results Program Data Base. Journal of Urology 169:3, pages 946-950.
Crossref
Crossref
D.B Kingsmore, A Ssemwogerere, D.J Hole, C.R Gillis & W.D George. (2003) Increased mortality from breast cancer and inadequate axillary treatment. The Breast 12:1, pages 36-41.
Crossref
Crossref
David W. Petrik, David R. McCready, Carol A. Sawka & Vivek Goel. (2003) Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. Journal of Surgical Oncology 82:2, pages 84-90.
Crossref
Crossref
S A Mcintosh & A D Purushotham. (1998) Lymphatic mapping and sentinel node biopsy in breast cancer. British Journal of Surgery 85:10, pages 1347-1356.
Crossref
Crossref
David N. Krag & Richard M. Single. (2003) Breast Cancer Survival According to Number of Nodes Removed. Annals of Surgical Oncology 10:10, pages 1152-1159.
Crossref
Crossref
J. Ahlgren, L. Holmberg, J. Bergh & G. Liljegren. (2002) Five-node biopsy of the axilla: an alternative to axillary dissection of levels I–II in operable breast cancer. European Journal of Surgical Oncology (EJSO) 28:2, pages 97-102.
Crossref
Crossref
Rob L.J.H. Bourez & Emiel J.Th. Rutgers. (2001) The European Organization for Research on Treatment of Cancer (eortc) Breast Cancer Group. Surgical Oncology Clinics of North America 10:4, pages 807-819.
Crossref
Crossref
John M. KaneIIIIII, Stephen B. Edge, Janet S. Winston, Nancy Watroba & Thelma C. Hurd. (2001) Intraoperative Pathologic Evaluation of a Breast Cancer Sentinel Lymph Node Biopsy as a Determinant for Synchronous Axillary Lymph Node Dissection. Annals of Surgical Oncology 8:4, pages 361-367.
Crossref
Crossref
Thorsten Kuehn, Wolfgang Klauss, Maren Darsow, Sylvia Regele, Felix Flock, Christa Maiterth, Reiner Dahlbender, Iris Wendt & Rolf Kreienberg. (2000) Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors. Breast Cancer Research and Treatment 64:3, pages 275-286.
Crossref
Crossref
Julia S Wong, Anne O’Neill, Abram Recht, Stuart J Schnitt, James L Connolly, Barbara Silver & Jay R Harris. (2000) The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?. International Journal of Radiation Oncology*Biology*Physics 48:1, pages 133-137.
Crossref
Crossref
Andrew J. Spillane & Nigel P. M. Sacks. (2001) ROLE OF AXILLARY SURGERY IN EARLY BREAST CANCER: REVIEW OF THE CURRENT EVIDENCE. Australian and New Zealand Journal of Surgery 70:7, pages 515-524.
Crossref
Crossref
Frans D. Rahusen, Rik Pijpers, Paul J. van Diest, Robert P. Bleichrodt, Hans Torrenga & Sybren Meijer. (2000) The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 128:1, pages 6-12.
Crossref
Crossref
Adri C. Voogd, Jan-Willem W. Coebergh, Ocker J. Repelaer van Driel, Rudi M.H. Roumen, Mike W.P.M. van Beek, Art Vreugdenhil & Mariad A. Crommelin. (2000) The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Research and Treatment 62:1, pages 63-69.
Crossref
Crossref
J. Leissner, R. Hohenfellner, J.W. Thüroff & H.K. Wolf. (2001) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU International 85:7, pages 817-823.
Crossref
Crossref
G. Cserni. (1999) The reliability of sampling three to six nodes for staging breast cancer. Journal of Clinical Pathology 52:9, pages 681-683.
Crossref
Crossref
Gábor Cserni. (1999) Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer. Pathology & Oncology Research 5:2, pages 129-133.
Crossref
Crossref
G. Cserni. (1998) How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short-term audit. Journal of Clinical Pathology 51:11, pages 846-849.
Crossref
Crossref
B Cutuli, M Velten, JF Rodier, JC Janser, P Quetin, D Jaeck, R Renaud & G Duperoux. (1998) Évaluation du risque d'envahissement ganglionnaire axillaire dans les cancers du sein inférieurs à 3 centimètres. Analyse d'un modèle prédictif à partir de 893 cas. Chirurgie 123:2, pages 175-182.
Crossref
Crossref
Julie Ann Sosa, Marie Diener-West, Yuriy Gusev, Michael A. Choti, Julie R. Lange, William C. Dooley & Martha A. Zeiger. (1998) Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Annals of Surgical Oncology 5:2, pages 140-149.
Crossref
Crossref
Masakuni Noguchi, Koichi Miwa, Takatoshi Michigishi, Kunihiko Yokoyama, Hiroshi Nishijima, Tsuyoshi Takanaka, Hiroko Kawashima, Shinobu Nakamura, Hiroshi Kanno & Akitaka Nonomura. (1997) The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4:3, pages 143-153.
Crossref
Crossref
Roderick R. Turner, David W. Ollila, David L. Krasne & Armando E. Giuliano. (1997) Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma. Annals of Surgery 226:3, pages 271-278.
Crossref
Crossref
Noel Weidner, Blake Cady & William H. GoodsonIIIIII. (1997) Pathologic Prognostic Factors for Patients with Breast Carcinoma. Surgical Oncology Clinics of North America 6:3, pages 415-462.
Crossref
Crossref
Nils K. Raabe, Rolf Kaaresen & Sophie D. Fossaa. (1997) Hospital-related differences in breast cancer management. Breast Cancer Research and Treatment 43:3, pages 225-235.
Crossref
Crossref
Douglas A. Fein, Barbara L. Fowble, Alexandra L. Hanlon, Mary A. Hooks, John P. Hoffman, Elin R. Sigurdson, Lori A. Jardines & Burton L. Eisenberg. (1997) Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. Journal of Surgical Oncology 65:1, pages 34-39.
Crossref
Crossref
Abram Recht & Mary J. Houlihan. (1995) Axillary lymph nodes and breast cancer. A review. Cancer 76:9, pages 1491-1512.
Crossref
Crossref
Christen K. Axelsson, Henning T. Mouridsen & Karin Zedeler. (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. European Journal of Cancer 28:8-9, pages 1415-1418.
Crossref
Crossref